MD.2 Medication Dispenser Medication Adherence Study

Status Recruiting

Clinical Trial Summary

The objective of this study is to quantify the benefits of using the MD.2 on health outcomes.

Clinical Trial Description

A sizeable portion of admissions to hospital and even nursing homes can be avoided if individuals with medication management problems were provided assistive devices to assist with their medications. The MD.2 medication dispenser and monitoring system was developed by Interactive Medical Developments LC and may offer increased support to the elderly with fewer human resources and a substantially reduced cost to the public health system. A rigorous evaluation of this technology has not been conducted. The objective of this Phase III clinical trial (Phase II of this STTR Fast Track Application) is to quantify the benefits of using the MD.2 on health outcomes. The specific aims are to: (1) Quantify healthcare utilization including hospitalizations and emergency room visits for MD.2 clients compared to control clients, (2) Determine the length of time in case management for MD.2 clients compared to control clients, (3) Measure changes in caregiver burden between those with the MD.2 and those with usual medication routines and (4) Determine if cognitive and functional characteristics influence compliance rates among the MD.2 clients and control clients. This study will be conducted in all counties in four of the Area Agencies on Aging in Iowa (who participated in the Phase I study), with the Veteran's Administration(VA)in Iowa, and with Area Agencies on Aging in Illinois. One hundred and fifty clients will be randomized to receive the MD.2 and 150 clients will be randomized to the control group. Primary caregivers for these 300 subjects will also be recruited. Nurses employed by Interactive Medical Developments LC will collect all data. From homecare charts/claims, age, sex, residence, living status, social support, activities of daily living, instrumental activities of daily living, cognition, medical conditions and medication lists will be obtained. Enrolled subjects will also complete an interviewer-administered survey of the Geriatric Depression Scale, SF-12 Health Status Inventory, self-reported medication compliance and recent hospitalizations and emergency room visits. Caregivers will complete the Caregiver Burden Interview. Poisson regression and Cox proportional hazards models will be the primary statistical approaches. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00560001
Study type	Interventional
Source	Interactive Medical Developments
Contact	Karen Farris, Ph.D.
Phone	319-384-4516
Email	karen-farris@uiowa.edu
Status	Recruiting
Phase	Phase 3
Start date	January 2006
Completion date	May 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02890927` - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital	N/A
Completed	`NCT00384709` - Geriatric Education and Its Effect on Certain Aspects of Hospital Care of Nursing Home Patients	N/A
Completed	`NCT05447533` - Clostridioides Difficile and Frailty	N/A
Completed	`NCT03722017` - Drug Reduction in Older Patients: The DROP Trial	N/A
Enrolling by invitation	`NCT05411393` - Synergizing Home Health Rehabilitation Therapy	N/A
Completed	`NCT03477097` - Frailty Prevention Through Improvement of Nutrition Physical Activity and Social Participation	N/A
Recruiting	`NCT02333214` - Effectiveness of a Program Using Video Games Associated With Conventional Physiotherapy in Physical Functioning in Frail Elderly Compared to Conventional Physiotherapy	N/A
Not yet recruiting	`NCT00756535` - Exercise Training in a Geriatric Hospital Ward	N/A
Completed	`NCT01829594` - Case Managers to Frail Older People a Randomized Controlled Trial	N/A
Recruiting	`NCT04095338` - Innovative Models in the Rehabilitation of the Elderly With Hip Fractures Through Technological Innovation	N/A
Completed	`NCT02975089` - A Pilot Study Comparing Effects of Nutrients Supplements and Dietary Approach in Frailty Management	N/A
Completed	`NCT01922167` - Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women	N/A
Completed	`NCT02591602` - Teleradiology Program for Frail Patients Living at Home or in Nursing-homes	N/A
Completed	`NCT00105781` - Nurse Physical Activity Counseling in Primary Care	N/A
Completed	`NCT05802537` - Home-Based Exergame Program for Community-Dwelling Older Adults	N/A
Completed	`NCT03990415` - Stay Strong, Stay Healthy Outcomes in Older Adults	N/A
Terminated	`NCT02766075` - A STEP for Patients Prior to Undergoing TAVR: A Pilot Study	N/A
Completed	`NCT01607736` - Pilot Study of Virtual Gait Training in Older Adults	N/A
Completed	`NCT00038155` - Rehabilitation for Older Adults From Acute Medical Conditions	Phase 2
Completed	`NCT04885608` - PReGe in Outdoor Fitness Parks	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.